Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Chinese mobile games developer Playtika completed its initial public offering, the largest of 2021 so far, raising $1.88 billion after selling 69.5 million shares at $27 each, well above the $22 to $24 price range.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $13.60 |
|---|---|
| 52-week range | $11.57 - $30.00 |
| 50-day moving average | $14.54 |
| 200-day moving average | $19.03 |
| Wall St. target price | $21.00 |
| PE ratio | 15.4545 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.88 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $13.6 from 2022-07-01
| 1 week (2022-06-27) | -5.49% |
|---|---|
| 1 month (2022-06-03) | -6.08% |
| 3 months (2022-04-05) | -30.33% |
| 6 months (2022-01-05) | -18.51% |
| 1 year (2021-07-02) | -41.13% |
|---|---|
| 2 years (2020-07-01) | N/A |
| 3 years (2019-07-01) | N/A |
| 5 years (2017-07-01) | N/A |
Valuing Playtika Holding stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Playtika Holding's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Playtika Holding's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Playtika Holding shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Playtika Holding's P/E ratio is best considered in relation to those of others within the electronic gaming & multimedia industry or those of similar companies.
Playtika Holding's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $655.3 million.
The EBITDA is a measure of a Playtika Holding's overall financial performance and is widely used to measure a its profitability.
To put Playtika Holding's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $2.6 billion |
|---|---|
| Operating margin TTM | 20.04% |
| Gross profit TTM | $1.9 billion |
| Return on assets TTM | 12.64% |
| Return on equity TTM | 0% |
| Profit margin | 13.58% |
| Book value | N/A |
| Market capitalisation | $5.6 billion |
TTM: trailing 12 months
We're not expecting Playtika Holding to pay a dividend over the next 12 months.
Playtika Holding Corp. develops mobile games in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company owns a portfolio of casual and casino-themed games. It distributes its games to the end customer through various web and mobile platforms, such as Apple, Facebook, Google, and other web and mobile platforms and its own proprietary platforms. The company was founded in 2010 and is headquartered in Herzliya Pituarch, Israel. Playtika Holding Corp. is a subsidiary of Playtika Holding Uk Ii Limited.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.